Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Bioharvest Sciences Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q1 2026
- Shares held
- 1.68M
- −18.3K (−1.1%) vs. Q1 2026
- Total value
- $4.80M
- −$2.58M (−34.9%) vs. Q1 2026
- New holders
- 2
- 6 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $4.80M |
| Q1 2026 | 20 | $7.38M |
| Q4 2025 | 22 | $8.48M |
| Q3 2025 | 9 | $2.44M |
| Q2 2025 | 8 | $724.7K |
| Q1 2025 | 8 | $802.6K |
| Q4 2024 | 6 | $545.4K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Bioharvest Sciences Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 9 | $0 | 0.00% | −3,000−99.7% | Reduced |
| Caitong International Asset Management Co., Ltd | 2 | $6 | 0.00% | +2 | New |
| National Bank of Canada | 154 | $423 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 173 | $495 | 0.00% | −456−72.5% | Reduced |
| Advisor Group Holdings, Inc. | 571 | $1.63K | 0.00% | −57−9.1% | Reduced |
| Morgan Stanley | 3,250 | $9.29K | 0.00% | 00.0% | Unchanged |
| K.J. Harrison & Partners Inc | 10,000 | $27.9K | 0.00% | +10,000 | New |
| Geode Capital Management, LLC | 10,558 | $29.8K | 0.00% | −1,253−10.6% | Reduced |
| XTX Topco Ltd | 13,232 | $37.3K | 0.00% | −16,417−55.4% | Reduced |
| Citadel Advisors LLC | 20,652 | $58.2K | 0.00% | +5,899+40.0% | Added |
| TD Waterhouse Canada Inc. | 23,827 | $65.5K | 0.00% | 00.0% | Unchanged |
| King Luther Capital Management Corp | 40,000 | $114.4K | 0.00% | 00.0% | Unchanged |
| Silverberg Bernstein Capital Management LLC | 57,723 | $162.8K | 0.06% | +31,624+121.2% | Added |
| Susquehanna International Group, LLP | 63,658 | $179.5K | 0.00% | +47,264+288.3% | Added |
| Magnus Financial Group LLC | 90,000 | $257.4K | 0.02% | +35,000+63.6% | Added |
| True North Advisors, LLC | 187,318 | $535.7K | 0.05% | +19,305+11.5% | Added |
| Evercore Wealth Management, LLC | 216,343 | $618.7K | 0.01% | +76,873+55.1% | Added |
| Thompson Siegel & Walmsley LLC | 364,008 | $1.04M | 0.02% | −22,751−5.9% | Reduced |
| Alyeska Investment Group, L.P. | 581,441 | $1.66M | 0.00% | −175,623−23.2% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,083−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −11,576−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −76−100.0% | Sold out |